BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22834701)

  • 1. Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies.
    Eppink B; Krawczyk PM; Stap J; Kanaar R
    Int J Hyperthermia; 2012; 28(6):509-17. PubMed ID: 22834701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents.
    IJff M; van Oorschot B; Oei AL; Krawczyk PM; Rodermond HM; Stalpers LJA; Kok HP; Crezee J; Franken NAP
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies.
    van den Tempel N; Odijk H; van Holthe N; Naipal K; Raams A; Eppink B; van Gent DC; Hardillo J; Verduijn GM; Drooger JC; van Rhoon GC; Smedts DHPM; van Doorn HC; Boormans JL; Jager A; Franckena M; Kanaar R
    Int J Hyperthermia; 2018 Jun; 34(4):407-414. PubMed ID: 28705099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors.
    Gaymes TJ; Shall S; Farzaneh F; Mufti GJ
    Haematologica; 2008 Dec; 93(12):1886-9. PubMed ID: 18838476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ.
    Iliakis G; Wu W; Wang M
    Int J Hyperthermia; 2008 Feb; 24(1):17-29. PubMed ID: 18214766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (ADP Ribose) Polymerase Inhibitors for Cancer: Essential Biologic, Diagnostic, and Therapeutic Concepts for Today's Practitioner.
    Sholl LM; Mandelker D; Stockley T
    J Mol Diagn; 2020 Sep; 22(9):1126-1128. PubMed ID: 32574701
    [No Abstract]   [Full Text] [Related]  

  • 8. Defective homologous recombination in human cancers.
    Cerbinskaite A; Mukhopadhyay A; Plummer ER; Curtin NJ; Edmondson RJ
    Cancer Treat Rev; 2012 Apr; 38(2):89-100. PubMed ID: 21715099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of temozolomide cytotoxicity by poly(ADP)ribose polymerase inhibitor ABT-888 requires a conversion of single-stranded DNA damages to double-stranded DNA breaks.
    Liu X; Shi Y; Guan R; Donawho C; Luo Y; Palma J; Zhu GD; Johnson EF; Rodriguez LE; Ghoreishi-Haack N; Jarvis K; Hradil VP; Colon-Lopez M; Cox BF; Klinghofer V; Penning T; Rosenberg SH; Frost D; Giranda VL; Luo Y
    Mol Cancer Res; 2008 Oct; 6(10):1621-9. PubMed ID: 18922977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the Achilles heel of cancer: the therapeutic potential of poly(ADP-ribose) polymerase inhibitors in BRCA2-defective cancer.
    Kyle S; Thomas HD; Mitchell J; Curtin NJ
    Br J Radiol; 2008 Oct; 81 Spec No 1():S6-11. PubMed ID: 18820000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
    Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
    Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.
    Peralta-Leal A; Rodríguez-Vargas JM; Aguilar-Quesada R; Rodríguez MI; Linares JL; de Almodóvar MR; Oliver FJ
    Free Radic Biol Med; 2009 Jul; 47(1):13-26. PubMed ID: 19362586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin Trapping of Factors Involved in DNA Replication and Repair Underlies Heat-Induced Radio- and Chemosensitization.
    Luzhin AV; Avanesyan B; Velichko AK; Shender VO; Ovsyannikova N; Arapidi GP; Shnaider PV; Petrova NV; Kireev II; Razin SV; Kantidze OL
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
    Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
    Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
    Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
    Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity.
    Lauber K; Brix N; Ernst A; Hennel R; Krombach J; Anders H; Belka C
    Cancer Lett; 2015 Nov; 368(2):209-29. PubMed ID: 25754814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human poly (ADP-ribose) polymerase 1 in Saccharomyces cerevisiae: Effect on survival, homologous recombination and identification of genes involved in intracellular localization.
    La Ferla M; Mercatanti A; Rocchi G; Lodovichi S; Cervelli T; Pignata L; Caligo MA; Galli A
    Mutat Res; 2015 Apr; 774():14-24. PubMed ID: 25779917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose)polymerase (PARP) inhibitors: from bench to bedside.
    Plummer R
    Clin Oncol (R Coll Radiol); 2014 May; 26(5):250-6. PubMed ID: 24602564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms.
    van den Tempel N; Horsman MR; Kanaar R
    Int J Hyperthermia; 2016 Jun; 32(4):446-54. PubMed ID: 27086587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting DNA repair in breast cancer: a clinical and translational update.
    Amir E; Seruga B; Serrano R; Ocana A
    Cancer Treat Rev; 2010 Nov; 36(7):557-65. PubMed ID: 20385443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.